RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?
about
Selective gene silencing by viral delivery of short hairpin RNANewer gene editing technologies toward HIV gene therapyRNAi induces innate immunity through multiple cellular signaling pathways.Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibitionWound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.RNA interference targeting enhancer of polycomb1 exerts anti-tumor effects in lung cancer.RNA interference approaches for treatment of HIV-1 infectionHumanized mouse models of HIV infectionConsidering RNAi experimental design in parasitic helminths.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.Lipid nanoparticle delivery systems for siRNA-based therapeutics.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.The therapeutic landscape of HIV-1 via genome editingThe effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells.Lipopeptide delivery of siRNA to the central nervous system.
P2860
Q21245112-E1F73E7E-F56B-4B48-8780-A846C106F4D5Q24631042-88B325A9-8BD3-40B8-884B-D2DAA4E0939DQ34735628-F396C212-9A6D-43A1-9647-20EA2EF5EEF2Q35024012-344CA9D4-E2E8-4369-82CC-FE9AA6F37C2FQ35078425-FC013F3E-A948-46C6-851A-053E19341812Q35144924-F87DE1E4-1055-4EC9-81FF-0E0B90EE1766Q35652119-FDC4AA4D-1271-4022-BE0F-012EFE40C83DQ37089865-89437672-7CFF-4BCC-9ABC-A825817C3674Q37973115-300E86E2-FD87-47B2-91DA-89A628652034Q38037048-73EC18B8-0A7D-4D04-9DE3-975D06C49EF9Q38788187-E32FDA3B-A9FA-4DC9-B4CA-F987BB8A0E3DQ39027758-2E85DAE7-0CFB-46F5-B14B-99FA82FED41EQ39038930-64CBA173-DB4C-4AFE-8E91-B69E2A973C21Q39153976-858A4893-CE30-4172-A9A3-31EBE8DF2314Q39447216-E85F2CD9-40D3-4019-9E9D-FFA7EBEBC009Q39512233-6405616F-BDB6-4E0A-8C7D-C5EC624ACA73Q46250876-97F3D3B4-CD31-4186-BA8A-3978424ED22B
P2860
RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@en
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@nl
type
label
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@en
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@nl
prefLabel
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@en
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@nl
P2093
P2860
P1476
RNA interference-based therape ...... c siRNA or vector-based shRNA?
@en
P2093
N Manjunath
Premlata Shankar
Sandesh Subramanya
Sang-Soo Kim
P2860
P304
P356
10.1517/14712590903448158
P407
P577
2010-02-01T00:00:00Z